Molecular targets and mechanisms of radiosensitization using DNA damage response pathways. Read more about Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.
Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer. Read more about Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer.
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Read more about Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer.
DNA amplifications in breast cancer: genotypic-phenotypic correlations. Read more about DNA amplifications in breast cancer: genotypic-phenotypic correlations.
Diagnostic markers and prognostic factors in thyroid cancer. Read more about Diagnostic markers and prognostic factors in thyroid cancer.
Translational research in glioblastoma multiforme: molecular criteria for patient selection. Read more about Translational research in glioblastoma multiforme: molecular criteria for patient selection.
Genome-wide association studies of cancer. Read more about Genome-wide association studies of cancer.
Aberrant kinase signaling: lessons from head and neck cancer. Read more about Aberrant kinase signaling: lessons from head and neck cancer.
State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma. Read more about State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma.
